Europe is the second largest pharmaceutical market after North America, accounting for more than 30% of the global pharmaceutical market in 2008. Growth rate in developed markets like Germany, France, Spain, UK and Italy has been observed decelerating for last few years, while the developing markets like Romania, Czech Republic and Ukraine have registered a significant increase in the growth rate. According to our new research report "Global Pharmaceutical Market Forecast to 2012", the pharmaceutical market in Europe is expected to grow at a CAGR of more than 6% during 2010-2012.
We have done an extensive research and prudent analysis of the European pharmaceutical industry in order to understand the factors that will continue to be the growth driver of pharma market in the region. We have found that that several factors such as growing healthcare concerns among people and increasing prevalence of lifestyle diseases will boost the market growth. Besides, several other factors propelling growth in the pharmaceutical industry have been thoroughly evaluated in the report.
Our research indicates that the pharmaceutical market in east European countries will grow more than the market of western countries. Mature markets condition and increasing use of generics products can be stated as two prime factors responsible for slow growth in the pharmaceutical markets of western European countries. We believe that there will be a shift in investments activities in Europe and more investments will be made in Research and Developments (R&D) and the sector will witness surge in M&A activities.
"Global Pharmaceutical Market Forecast to 2012" provides valuable information and reliable statistics of the global pharmaceutical market, with focus on its current and future prospects. Apart from the European region, the report includes the study of pharmaceutical markets in different countries of other geographical regions - North America, Latin America, Asia-Pacific and Africa. The report has thoroughly examined industrial developments and competitive landscape to enable clients understand the market structure and its progress in coming years.
For more information visit: http://www.rncos.com/Report/IM149.htm |
